Company Isodiol International Inc Other OTC
Equities
CA46500L1013
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Nutritional Health Products
100.0
%
| 19 | 100.0 % | 22 | 100.0 % | +16.26% |
Sales per region
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 19 | 100.0 % | 22 | 100.0 % | +16.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/17/24 |
Director/Board Member | - | 30/18/30 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/19/14 |
Dianne Szigety
SEC | Corporate Secretary | 69 | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/17/24 |
Director/Board Member | - | 30/18/30 | |
Director/Board Member | - | 21/18/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 98,334,359 | 98,334,359 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+42.64% | 638.37Cr | |
-15.52% | 458.98Cr | |
+8.35% | 339Cr | |
-11.10% | 320.43Cr | |
-4.12% | 251.81Cr | |
+46.46% | 200.45Cr | |
-7.97% | 170.19Cr | |
-1.07% | 164.59Cr | |
-11.56% | 157.66Cr |